Search research articles
Contact Us
Filters
Showing results (51-60 of 53) with videos related to
Page
of 6
Sort By:
You have reached the last page of results.
This site can display upto 53 results.
Clinical and Translational Radiation Oncology
|
March 27, 2023
Randomized phase II trial in prostate cancer with hormone-sensitive OligometaSTatic relapse: Combining stereotactic ablative radiotherapy and durvalumab (POSTCARD GETUG P13): Study protocol
Maximilien Rogé, Yoann Pointreau, Paul Sargos, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
April 12, 2024
Recommendations for Post-Operative RadioTherapy After Complete Resection of Thymoma-a French DELPHI Consensus Initiative
Clémence Basse, Jonathan Khalifa, François Thillays, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
March 4, 2017
Phase II Study of a Radiotherapy Total Dose Increase in Hypoxic Lesions Identified by <sup>18</sup>F-Misonidazole PET/CT in Patients with Non-Small Cell Lung Carcinoma (RTEP5 Study)
Pierre Vera, Sébastien Thureau, Philippe Chaumet-Riffaud, et al.
Page
of 6
Search research articles
Search
Showing results (51-60 of 53) with videos related to
Sort By:
Page
of 6
You have reached the last page of results.
This site can display upto 53 results.
Clinical and Translational Radiation Oncology
|
March 27, 2023
Randomized phase II trial in prostate cancer with hormone-sensitive OligometaSTatic relapse: Combining stereotactic ablative radiotherapy and durvalumab (POSTCARD GETUG P13): Study protocol
Maximilien Rogé, Yoann Pointreau, Paul Sargos, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
April 12, 2024
Recommendations for Post-Operative RadioTherapy After Complete Resection of Thymoma-a French DELPHI Consensus Initiative
Clémence Basse, Jonathan Khalifa, François Thillays, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
March 4, 2017
Phase II Study of a Radiotherapy Total Dose Increase in Hypoxic Lesions Identified by <sup>18</sup>F-Misonidazole PET/CT in Patients with Non-Small Cell Lung Carcinoma (RTEP5 Study)
Pierre Vera, Sébastien Thureau, Philippe Chaumet-Riffaud, et al.
Page
of 6